EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Discovery of Dolutegravir Derivative against Liver Cancer via Inducing Autophagy and DNA Damage

Xixi Hou, Dong Yan, Ziyuan Wu, Longfei Mao, Huili Wang, Yajie Guo, Jianxue Yang

Molecules · 2024

DOI: 10.3390/molecules29081779 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Xixi Hou und 6 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, Luoyang 471003, China. Hauptthemen laut MEDLINE: Pyridones, Autophagy, DNA Damage, Liver Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: International Science and Technology Cooperation Project of Henan Province of China, 2023 Henan Province Central guidance and local science and technology development, Key Scientific Research Projects of Universities in Henan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We introduced a terminal alkyne into the core structure of dolutegravir, resulting in the synthesis of 34 novel dolutegravir-1,2,3-triazole compounds through click chemistry. These compounds exhibited remarkable inhibitory activities against two hepatocellular carcinoma cell lines, Huh7 and HepG2. Notably, compounds 5e and 5p demonstrated exceptional efficacy, particularly against Huh7 cells, with IC50 values of 2.64 and 5.42 μM. Additionally, both compounds induced apoptosis in Huh7 cells, suppressed tumor cell clone formation, and elevated reactive oxygen species (ROS) levels, further promoting tumor cell apoptosis. Furthermore, compounds 5e and 5p activated the LC3 signaling pathway, inducing autophagy, and triggered the γ-H2AX signaling pathway, resulting in DNA damage in tumor cells. Compound 5e exhibited low toxicity, highlighting its potential as a promising anti-tumor drug.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyridonesAutophagyDNA DamageLiver NeoplasmsPiperazinesOxazinesHeterocyclic Compounds, 3-RingAntineoplastic AgentsApoptosisReactive Oxygen SpeciesHumansCell Line, TumorHep G2 CellsCarcinoma, HepatocellularSignal TransductionCell ProliferationDrug DiscoveryDolutegravir

Stichwörter der Autor:innen

1,2,3-triazoleanti-tumordolutegravirhepatocellular carcinoma cell lines DNA damage

Substanzen

PyridonesPiperazinesOxazinesHeterocyclic Compounds, 3-RingAntineoplastic AgentsReactive Oxygen SpeciesDolutegravir

Autor:innen und Institutionen

  • The First Affiliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, Luoyang 471003, China.
  • College of Basic Medicine and Forensic Medicine, Henan University of Science and Technology, 263 Kaiyuan Road, Luoyang 471003, China.
  • University of North Carolina Hospitals, 101 Manning Dr, Chapel Hill, Orange County, NC 27599, USA.
  • Department of Emergency, The Eighth Affiliated Hospital, Sun Yat-sen University, Shenzhen 518033, China.

Förderung

  • International Science and Technology Cooperation Project of Henan Province of China
  • 2023 Henan Province Central guidance and local science and technology development
  • Key Scientific Research Projects of Universities in Henan Province
  • Henan Province Medical Science and Technology Research Project
  • College Students’ Innovative Entrepreneurial Training Plan Program

Zitieren

APA

Hou, X., Yan, D., Wu, Z., Mao, L., Wang, H., Guo, Y., & Yang, J. (2024). Discovery of Dolutegravir Derivative against Liver Cancer via Inducing Autophagy and DNA Damage. Molecules. https://doi.org/10.3390/molecules29081779

Vancouver

Hou X, Yan D, Wu Z, Mao L, Wang H, Guo Y, et al. Discovery of Dolutegravir Derivative against Liver Cancer via Inducing Autophagy and DNA Damage. Molecules. 2024. doi:10.3390/molecules29081779

BibTeX
@article{Hou2024,
  author = {Hou, Xixi and Yan, Dong and Wu, Ziyuan and Mao, Longfei and Wang, Huili and Guo, Yajie and Yang, Jianxue},
  title = {Discovery of Dolutegravir Derivative against Liver Cancer via Inducing Autophagy and DNA Damage},
  journal = {Molecules},
  year = {2024},
  doi = {10.3390/molecules29081779}
}
Kostenlos starten →